ClinicalTrials.Veeva

Menu

Myotonic Dystrophy Type 1 and Resistance Exercise (STYRK DM1)

N

Norwegian School of Sport Sciences

Status

Completed

Conditions

Myotonic Dystrophy 1

Treatments

Other: Moderate-Heavy Resistance Exercise

Study type

Interventional

Funder types

Other

Identifiers

NCT05036447
STYRK DM1

Details and patient eligibility

About

The purpose of this study is to investigate the response after one bout of moderate-heavy resistance exercise in patients suffering from Myotonic Dystrophy type 1. There is still doubt about if these patients could benefit from resistance exercise, or if this mode of exercise is detrimental to their mobility and health. We aim to monitor the subjects during the recovery phase and investigate recovery in several ways.

Full description

Myotonic dystrophy type 1 (DM1) is an autosomal, dominantly inherited, muscular disease and the most common muscular dystrophy amongst adults. The disease is characterized by progressive myopathy and myotonia, first evident in the distal parts of the body: calves and forearms, further progressing towards proximal parts. A recent review by Voet and co-workers (2013) concludes that exercise is safe for DM1-patients, and based on our current knowledge, DM1-patients should be able to gain positive adaptations from exercise. However, the physiological outcomes of an exercise stimulus are not well studied in this population and because of alterations in important Ca2+ handling systems the recovery processes might be significantly different from healthy muscles.

The aim of this study is to investigate the acute responses to moderate-heavy resistance exercise in DM1-patients. We aim to establish a timeline for recovery of muscle strength, measured as maximal voluntary contraction. In line with this, we want to investigate if any muscular damage has occurred with both direct and indirect measures, and possible mechanisms leading to muscle damage, i.e. impaired Ca2+ handling.

Enrollment

21 patients

Sex

All

Ages

18 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Confirmed Myotonic Dystrophy type 1-diagnosis

Exclusion criteria

  • Non-ambulatory
  • Injuries to muscle-skeletal-system that prevents resistance exercise
  • Severe affection of the cardiovascular system
  • Cognitive affection
  • Lives more than one hour from test site

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Single Blind

21 participants in 4 patient groups

DM1-Ex
Experimental group
Description:
Moderate-heavy resistance exercise of one leg in DM1-patients
Treatment:
Other: Moderate-Heavy Resistance Exercise
DM1-Rest
No Intervention group
Description:
Control leg (i.e. no exercise) in DM1-patients
Ctrl-Ex
Experimental group
Description:
Moderate-heavy resistance exercise of one leg in healthy participants
Treatment:
Other: Moderate-Heavy Resistance Exercise
Ctrl-Rest
No Intervention group
Description:
Control leg (i.e. no exercise) in healthy participants

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems